This is the authors' abstract. We don't add key points for this paper.
Neonatal alloimmune thrombocytopenia (NAIT), which usually involves sensitization to P1A1 (HPA-1a), may have devastating complications for the fetus. These may be prevented by antenatal treatment of severe cases with either maternally administered high-dose gamma-globulin and/or repeated intrauterine platelet transfusions. Determination of the paternal platelet phenotype is useful for counseling parents who have had one or more affected pregnancies. This report of an unaffected pregnancy in a woman with a history of previous pregnancies complicated by NAIT illustrates the role of paternal and fetal platelet phenotyping in managing existing pregnancies at risk of NAIT.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Lipitz et al. (1992) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: